Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Innate Pharma First Half 2025 Business Update and Financial Results Conference Call. [Operator Instructions].
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 26,617 | $46,580 | +10% | 0% |
| 2. | Millennium Management Israel Englander | 11,661 | $20,407 | -24% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,281 | $4,402 | 0% | |
| 2. | 10 | $19 | 0% |